Nicholas L. Stucky

Infectious Disease

834 Sheridan St
Port Townsend, WA 98368

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: multi-target trial emulation study.

Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: multi-target trial emulation study.

Journal: BMJ open

Published: July 21, 2026

Real-world switching and switch-back patterns among patients transitioning from adalimumab to biosimilars in the United States (February 2023 to August 2025).

Real-world switching and switch-back patterns among patients transitioning from adalimumab to biosimilars in the United States (February 2023 to August 2025).

Journal: Journal of managed care & specialty pharmacy

Published: June 24, 2026

Heart Failure Trajectories After Guideline-Directed Medical Therapy.

Heart Failure Trajectories After Guideline-Directed Medical Therapy.

Journal: JAMA network open

Published: May 21, 2026

Delayed or Absent First Dose of Measles, Mumps, and Rubella Vaccination.

Delayed or Absent First Dose of Measles, Mumps, and Rubella Vaccination.

Journal: JAMA network open

Published: January 02, 2026

FDA Cardiovascular Indication Expansion and Dispensing of Semaglutide/Tirzepatide in CVD Patients With Overweight/Obesity.

FDA Cardiovascular Indication Expansion and Dispensing of Semaglutide/Tirzepatide in CVD Patients With Overweight/Obesity.

Journal: JACC. Advances

Published: November 24, 2025

FDA Cardiovascular Indication Expansion and Dispensing of Semaglutide/Tirzepatide in CVD Patients With Overweight/Obesity.

FDA Cardiovascular Indication Expansion and Dispensing of Semaglutide/Tirzepatide in CVD Patients With Overweight/Obesity.

Journal: JACC. Advances

Published: November 24, 2025

Early MMR Vaccine Adoption During the 2025 Texas Measles Outbreak.

Early MMR Vaccine Adoption During the 2025 Texas Measles Outbreak.

Journal: JAMA network open

Published: November 14, 2025

From fragmented records to living evidence: health system-governed, artificial intelligence-driven, continuously updated real-world clinical data from Truveta.

From fragmented records to living evidence: health system-governed, artificial intelligence-driven, continuously updated real-world clinical data from Truveta.

Journal: JAMIA open

Published: September 18, 2025

Evaluating changes in lidocaine and opioid administration on the day of IUD insertion, 2018-2025.

Evaluating changes in lidocaine and opioid administration on the day of IUD insertion, 2018-2025.

Journal: Contraception

Published: July 30, 2025

XComposition: multimodal deep learning model to measure body composition using chest radiographs and clinical data.

XComposition: multimodal deep learning model to measure body composition using chest radiographs and clinical data.

Journal: Radiology advances

Published: June 17, 2025

Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity.

Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity.

Journal: JAMA network open

Published: January 31, 2025

Semaglutide vs Tirzepatide Dosages for Weight Loss-Reply.

Semaglutide vs Tirzepatide Dosages for Weight Loss-Reply.

Journal: JAMA internal medicine

Published: November 25, 2024

Showing 1-12 of 20

Last Updated: 09/26/2026